# Liraglutide In Overweight Patients With Type 1 Diabetes

> **NCT01753362** · PHASE3 · COMPLETED · sponsor: **University at Buffalo** · enrollment: 84 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** liraglutide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01753362
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-02
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753362, "Liraglutide In Overweight Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01753362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*